Clinical Expert Commentaries

Dr. Peter Johnson discusses the pros and cons of using PET and FDG-PET scanning in the management of Hodgkin lymphoma.

Dr. Engert provides an update on the HD13 clinical trial and discusses the AETHERA trial, focusing on maintenance.

Dr. Armitage discusses AVBD and BEACOPP treatment regimens as options for advanced-stage Hodgkin lymphoma patients.

Dr. Armitage discusses surveillance imaging, such as CT and PET scans, as a tool to diagnose disease progression.

Dr. Diehl discusses the history and pioneering leadership that has developed into current standard of the treatment of Hodgkin lymphoma.

Dr. Hoppe discusses the role of radiotherapy in both early and late stage Hodgkin lymphoma.

Dr. Cavalli discusses utilizing PET and CT scans in conjunction with the therapeutic regimens of AVBD and BEACOPP for patients with relapsed/refractory Hodgkin lymphoma.

Dr. James Armitage discusses the standard of care for patients with relapsed or primarily refractory Hodgkin lymphoma.
Results 1 - 8 of 8